|
|
|
Insider
Information: |
Schroeder Theodore R |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
22,996 |
|
Indirect Shares
|
117,489 |
|
|
Direct
Value |
$369,493 |
|
|
Indirect Value
|
$46,267 |
|
|
Total
Shares |
140,485 |
|
|
Total
Value |
$415,760 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-100.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cadence Pharmaceuticals Inc |
CADX |
President, CEO, Director |
2014-03-19 |
0 |
2014-03-19 |
0 |
Premium* |
|
Hyperion Therapeutics Inc |
HPTX |
Director |
2015-05-07 |
0 |
2014-08-13 |
0 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2020-05-20 |
11,007 |
2018-05-24 |
0 |
Premium* |
|
Nabriva Therapeutics AG |
NBRV |
Director |
2023-01-29 |
11,989 |
2019-08-27 |
117,489 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HPTX |
Hyperion Therapeutics Inc |
Director |
|
2015-05-07 |
4 |
D |
$46.00 |
$141,818 |
D/D |
(3,083) |
0 |
0 |
- |
|
HPTX |
Hyperion Therapeutics Inc |
Director |
|
2015-05-07 |
4 |
D |
$46.00 |
$28,382 |
D/D |
(617) |
0 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2014-03-19 |
4 |
D |
$14.00 |
$4,305,000 |
I/I |
(307,500) |
0 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2014-03-19 |
4 |
D |
$14.00 |
$177,296 |
D/D |
(12,664) |
0 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2009-10-16 |
4 |
AS |
$10.72 |
$214,376 |
I/I |
(20,000) |
491,000 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2010-01-04 |
4 |
AS |
$9.80 |
$101,363 |
I/I |
(10,343) |
461,000 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2009-12-31 |
4 |
AS |
$9.76 |
$191,866 |
I/I |
(19,657) |
471,343 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2010-03-31 |
4 |
AS |
$9.30 |
$260,330 |
I/I |
(28,003) |
432,997 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2010-04-01 |
4 |
AS |
$9.03 |
$198,626 |
I/I |
(21,997) |
411,000 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2010-09-30 |
4 |
AS |
$8.35 |
$339,691 |
I/I |
(40,703) |
320,297 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2010-10-01 |
4 |
AS |
$8.35 |
$77,670 |
I/I |
(9,297) |
311,000 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2011-05-17 |
4 |
B |
$7.48 |
$119,626 |
I/I |
16,000 |
307,500 |
2.66 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2010-06-30 |
4 |
AS |
$7.00 |
$287,250 |
I/I |
(41,021) |
369,979 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2010-07-01 |
4 |
AS |
$6.95 |
$62,401 |
I/I |
(8,979) |
361,000 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2011-11-02 |
4 |
D |
$5.72 |
$41,962 |
D/D |
(7,336) |
12,664 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
President, CEO |
|
2008-02-20 |
4 |
A |
$5.34 |
$58,740 |
I/I |
11,000 |
511,000 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2021-02-06 |
4 |
D |
$2.90 |
$7,816 |
D/D |
(2,695) |
178,985 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-10-06 |
4 |
D |
$2.72 |
$24 |
D/D |
(9) |
12,465 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2021-01-31 |
4 |
D |
$2.62 |
$328 |
D/D |
(125) |
181,893 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-10-31 |
4 |
D |
$2.54 |
$13 |
D/D |
(5) |
12,460 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2020-12-31 |
4 |
D |
$2.42 |
$293 |
D/D |
(121) |
64,518 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2021-02-28 |
4 |
D |
$2.39 |
$253 |
D/D |
(106) |
181,787 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-11-30 |
4 |
D |
$2.25 |
$11 |
D/D |
(5) |
12,445 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-11-06 |
4 |
D |
$2.24 |
$22 |
D/D |
(10) |
12,450 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
|
2022-09-30 |
4 |
D |
$2.08 |
$10 |
D/D |
(5) |
12,474 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|